1955 Primary Systemic Therapy by Dual HER2 Blockage with Lapatinib (la) + Trastuzumab (T) for Japanese Patients (pts) with HER2+ Breast Cancer (BC): Association of La Toxicity and Dose with Treatment Efficacy
European journal of cancer(2015)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined